The hypothesis that EPO may be an effective neurotrophic and neuroprotective molecule originates from observations obtained with EPO-releasing neural precursors cells (Er-NPCs) transplantation in an animal experimental model of PD obtained by MPTP administration [37,38]. The gene discussed is EPO; the disease is Parkinson disease.